ENSYSCE BIOSCIENCES, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/66a0de90-81a0-4628-bc29-cd6991ed681c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $5.1M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-013633 |
| FY 2024 | $5.2M | 2024-01-01 – 2024-12-31 | evidence 0001493152-25-009703 |
| FY 2023 | $2.2M | 2023-01-01 – 2023-12-31 | evidence 0001493152-24-009993 |
| FY 2022 | $2.5M | 2022-01-01 – 2022-12-31 | evidence 0001493152-23-009844 |
| FY 2021 | $3.5M | 2021-01-01 – 2021-12-31 | evidence 0001493152-23-009844 |
| FY 2020 | $3.9M | 2020-01-01 – 2020-12-31 | evidence 0001493152-22-008438 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ENSYSCE BIOSCIENCES, INC. — all facts · Net Income · Operating Income